Document is current

Any future updates will be listed below

EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex

Crossref DOI link: https://doi.org/10.1186/s12883-016-0658-4

Published Online: 2016-08-08

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark